Risk Factors Associated With the Onset and Progression of Posttransplantation Diabetes in Renal Allograft Recipients

  1. Kyu Yeon Hur, MD, PHD1,
  2. Myoung Soo Kim, MD, PHD2,
  3. Yu Seun Kim, MD, PHD2,
  4. Eun Seok Kang, MD, PHD13,
  5. Jae Hyun Nam, MD, PHD1,
  6. So Hun Kim, MD1,
  7. Chung Mo Nam, PHD4,
  8. Chul Woo Ahn, MD, PHD13,
  9. Bong Soo Cha, MD, PHD13,
  10. Soon Il Kim, MD, PHD2 and
  11. Hyun Chul Lee, MD, PHD13
  1. 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
  2. 2Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
  3. 3Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea
  4. 4Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
  1. Soon Il Kim, MD, PhD, Department of Surgery, Yonsei University College of Medicine, 134 Shinchon-Dong Seodaemun-Gu, Seoul, 120-752, Korea. E-mail: soonkim{at}yumc.yonsei.ac.kr
  2. Address correspondence and reprint requests to Hyun Chul Lee, MD, PhD, Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong Seodaemun-Gu, Seoul, 120-752, Korea. E-mail: endohclee{at}yumc.yonsei.ac.kr

Abstract

OBJECTIVE—The aim of this study was to assess the incidence of posttransplantation diabetes mellitus (PTDM) in renal allograft recipients and to investigate factors contributing to the onset and progression of PTDM and its underlying pathogenic mechanism(s).

RESEARCH DESIGN AND METHODS—A total of 77 patients with normal glucose tolerance (NGT) were enrolled in this study. An oral glucose tolerance test was performed 1 week before transplantation and repeated at 1 and 7 years after transplantation.

RESULTS—The overall incidence of PTDM was 39% at 1 year and 35.1% at 7 years posttransplantation. The incidence for each category of PTDM was as follows: persistent PTDM (P-PTDM) (patients who developed diabetes mellitus within 1 year of transplantation and remained diabetic during 7 years), 23.4%; transient PTDM (T-PTDM) (patients who developed diabetes mellitus during the 1st year after transplantation but eventually recovered to have NGT), 15.6%; late PTDM (L-PTDM) (patients who developed diabetes mellitus later than 1 year after transplantation), 11.7%; and non-PTDM during 7 years (N-PTDM7) (patients who did not develop diabetes mellitus during 7 years), 49.3%. Older age (≥40 years) at transplantation was a higher risk factor for P-PTDM, whereas a high BMI (≥25 kg/m2) and impaired fasting glucose (IFG) at 1 year posttransplantation were higher risk factors for L-PTDM. Impaired insulin secretion rather than insulin resistance was significantly associated with the development of P- and L-PTDM.

CONCLUSIONS—Impaired insulin secretion may be the main mechanism for the development of PTDM. Older age at transplantation seems to be associated with P-PTDM, whereas a high BMI and IFG at 1 year after transplantation were associated with L-PTDM.

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted November 4, 2006.
    • Received June 20, 2006.
« Previous | Next Article »Table of Contents

This Article

  1. doi: 10.2337/dc06-1277 Diabetes Care March 2007 vol. 30 no. 3 609-615
  1. » Abstract
  2. Full Text
  3. Full Text (PDF)

Current Issue

  1. March 2010, 33 (3)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care